Skip to content

Micra™ AV2 MC2AVR1

by Medtronic, Inc.

Micra AV2 MC2AVR1 is an intracardiac pacemaker (FDA Class III; FDA product code PNJ, Leadless pacemaker) made by Medtronic, Inc., approved under FDA PMA P150033 on 6 Apr 2016 and listed in FDA GUDID since 5 May 2023 (UDI-DI 00763000078645), active as of 23 Oct 2026. 2 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

2 ongoing

Recall on shared PMA P150033; other models may be affected

Documents

PMA P150033

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00763000078645 UDI-DI Date5 May 2023ListedStatusListed GUDID: in commercial distribution
United StatesFDA PMAAPPR from GUDID Approved NumberP150033 Date6 Apr 2016DecidedStatusActive

Official records

From the FDA record

Device description
TPS MC2AVR1 MICRA AV2 US
MRI safety
MR Conditional
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA PMA P150033 decided 6 Apr 2016 Active
  • FDA GUDID UDI-DI 00763000078645 listed 5 May 2023 Listed

Recalls

4 recalls · 2 ongoing · FDA

  • 2 recalls, same reason

    • Ongoing Z-2128-2025 FDA Class II initiated 17 Jun 2025 on shared PMA P150033
    • Ongoing Z-2127-2025 FDA Class II initiated 17 Jun 2025 on shared PMA P150033

    A software update for Medtronic CareLink SmartSync Device Manager (SmartSync) is now available. The update eliminates the potential display of an erroneous electrical reset (pop-up) message upon interrogation with a SmartSync Device Manager. The erroneous message indicates an electrical reset has occurred. However, no reset has actually occurred and there are no parameter changes or loss of diagnostics. Prior to this software update, if an erroneous SmartSync message was displayed, confusion regarding the message could have caused a clinician to consider an unnecessary system revision. Medtronic has received 39 reports of this display error with two instances of unnecessary device explant through 30 April 2025.

  • 2 recalls, same reason

    • Terminated Z-2492-2019 FDA Class II initiated 6 Aug 2019
    • Terminated Z-2493-2019 FDA Class II initiated 6 Aug 2019

    Medtronic is updating the Micra Instructions for Use (IFU) and the Micra Implant Procedure Tip Card to include specific information on the removal of the tether to release the Micra Pacemaker from the Micra Delivery System during implant.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

6 dated events

  1. Approved FDA PMA P150033
  2. Recall initiated FDA recalls Z-2492-2019
  3. Recall initiated FDA recalls Z-2493-2019
  4. Listed FDA GUDID 00763000078645
  5. Recall initiated FDA recalls Z-2128-2025
  6. Recall initiated FDA recalls Z-2127-2025

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

GUDID

Trade name
Micra™ AV2
Generic name
Intracardiac pacemaker
Model / reference
MC2AVR1
Primary DI / UDI-DI
00763000078645
PMA number
FDA product code
PNJ
GMDN term
Intracardiac pacemaker
Device class
Class III
Regulation number
870.3610
GUDID distribution status
In Commercial Distribution
MRI safety
MR Conditional
Size
Catheter Working Length — 105.0 Centimeter
Catheter Gauge — 23.0 French

Other devices from Medtronic, Inc.

See all devices from Medtronic, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Combination product
  • Serial number
Other properties (9, all answered No)